Ranbaxy enters the dragon for biotech
Ranbaxy Laboratories has marked its entry in the biotechnology areas by signing in-licencing agreements for three products with two Chinese and Korean company. While interferon-alpha 2b and G-CSF
Ranbaxy Laboratories has marked its entry in the biotechnology areas by signing in-licencing agreements for three products with two Chinese and Korean company. While interferon-alpha 2b and G-CSF